Bavarian Nordic A/S - BAVA.CO

BAVA.CO Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BAVA.CO	-1.9	0.3	1.6	-12.3	4.1	21.5	-0.3	-0.4	-6.5	119.4
S&P 500	0.6	1.5	2.6	4.0	9.4	25.5	38.0	83.2	195.0	34364.2

Compare BAVA.CO with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BAVA.CO
name	Bavarian Nordic A/S
price	195.9
changes percentage	-1.8537
change	-3.7
day low	195.4
day high	204.4
year high	300
year low	143.4
market cap	15407576335
price avg 50	193.909
price avg 200	197.623
exchange	CPH
volume	211078
avg volume	356294
open	200
previous close	199.6
eps	14.51
pe	13.5
earnings announcement	2025-03-05T10:59:00.000+0000
shares outstanding	78650211
timestamp	2025-01-22 15:59:39

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 75.3%

Overall Quarterly Financial Health: 50.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	7062340000	3150793000	124.14
gross profit	4526769000	1701262000	166.08
gross profit ratio	0.64	0.54	18.71
research and development expenses	2228080000	1183092000	88.33
operating expenses	3024230000	1772047000	70.66
interest income	40214000	26000	154569.23
interest expense	105519000	119689000	-11.84
ebitda	2051791000	84276000	2334.61
ebitdaratio	0.29	0.13	131.51
operating income	1497523000	-3845000	39047.28
operating income ratio	0.21	-0.0	17475.94
net income	1475189000	-347382000	524.66
net income ratio	0.21	-0.11	289.46
eps	19.23	-4.93	490.06

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 7,062 million in 2023 from 3,151 million in 2022 representing a change of 124.14%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 4,527 million in 2023 from 1,701 million in 2022 representing a change of 166.08%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2,228 million in 2023 from 1,183 million in 2022 representing a change of 88.33%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 1,498 million in 2023 from -4 million in 2022 representing a change of 39047.28%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 1,475 million in 2023 from -347 million in 2022 representing a change of 524.66%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 19.23 in 2023 from 19.23 in 2022 representing a change of 490.06%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 3,024 million in 2023 from 1,772 million in 2022 representing a change of 70.66%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 2,052 million in 2023 from 84 million in 2022 representing a change of 2334.61%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	1363361000	1427497000	-4.49
gross profit	579598000	719950000	-19.49
gross profit ratio	0.43	0.5	-15.71
research and development expenses	264278000	209587000	26.09
operating expenses	579598000	454057000	27.65
interest income	9361000	9549000	-1.97
interest expense	23482000	21392000	9.77
ebitda	252835000	441029000	-42.67
ebitdaratio	0.19	0.31	-39.97
operating income	93570000	265893000	-64.81
operating income ratio	0.07	0.19	-63.15
net income	70492000	261128000	-73.00
net income ratio	0.05	0.18	-71.73
eps	0.9	3.3	-72.73

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,363 million in 2024Q3 from 1,427 million in 2024Q2 representing a change of -4.49%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 580 million in 2024Q3 from 720 million in 2024Q2 representing a change of -19.49%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 580 million in 2024Q3 from 454 million in 2024Q2 representing a change of 27.65%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 253 million in 2024Q3 from 441 million in 2024Q2 representing a change of -42.67%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 0.9 in 2024Q3 from 0.9 in 2024Q2 representing a change of -72.73%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 264 million in 2024Q3 from 210 million in 2024Q2 representing a change of 26.09%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 94 million in 2024Q3 from 266 million in 2024Q2 representing a change of -64.81%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 70 million in 2024Q3 from 261 million in 2024Q2 representing a change of -73.0%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	14353213000	12391246000	15.83
total liabilities	4013281000	5241259000	-23.43
total equity	10339932000	7149987000	44.61
cash and cash equivalents	1477234000	575407000	156.73
short term investments	390247000	2269759000	-82.81
long term investments	11185000	5086000	119.92
total current assets	5403051000	4484580000	20.48
total non current assets	8950162000	7906666000	13.20
total current liabilities	2787869000	2287340000	21.88
total non current liabilities	1225412000	2953919000	-58.52
common stock	780978000	707354000	10.41
retained earnings	9330002000	6300575000	48.08
total debt	145302000	1759332000	-91.74

Overall Score of Annual Balance Sheet

0.8 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 14,353 million in 2023 from 12,391 million in 2022 representing a change of 15.83%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 4,013 million in 2023 from 5,241 million in 2022 representing a change of -23.43%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 10,340 million in 2023 from 7,150 million in 2022 representing a change of 44.61%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,477 million in 2023 from 575 million in 2022 representing a change of 156.73%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 5,403 million in 2023 from 4,485 million in 2022 representing a change of 20.48%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 781 in 2023 from 707 in 2022 representing a change of 10.41%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 9,330 million in 2023 from 6,301 million in 2022 representing a change of 48.08%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 145 million in 2023 from 1,759 million in 2022 representing a change of -91.74%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 390 million in 2023 from 2,270 million in 2022 representing a change of -82.81%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 2,788 million in 2023 from 2,287 million in 2022 representing a change of 21.88%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	13948777000	14274445000	-2.28
total liabilities	3263638000	3837728000	-14.96
total equity	10685139000	10436717000	2.38
cash and cash equivalents	996692000	816402000	22.08
short term investments	874802000	1420782000	-38.43
long term investments	0	9445000	-100.00
total current assets	5189798000	5390533000	-3.72
total non current assets	8758979000	8883912000	-1.41
total current liabilities	3079228000	3649400000	-15.62
total non current liabilities	184410000	188327999	-2.08
common stock	788329000	781165000	0.92
retained earnings	9672409000	9461138000	2.23
total debt	114301000	124612000	-8.27

Overall Score of Quarterly Balance Sheet

0.7 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 13,949 million in 2024Q3 from 14,274 million in 2024Q2 representing a change of -2.28%. Suggesting a decrease in asset holdings.

  Short Term Investments: Short Term Investments decreased to 875 million in 2024Q3 from 1,421 million in 2024Q2 representing a change of -38.43%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 5,190 million in 2024Q3 from 5,391 million in 2024Q2 representing a change of -3.72%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 3,264 million in 2024Q3 from 3,838 million in 2024Q2 representing a change of -14.96%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 10,685 million in 2024Q3 from 10,437 million in 2024Q2 representing a change of 2.38%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 997 million in 2024Q3 from 816 million in 2024Q2 representing a change of 22.08%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 3,079 million in 2024Q3 from 3,649 million in 2024Q2 representing a change of -15.62%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 788 in 2024Q3 from 781 in 2024Q2 representing a change of 0.92%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 9,672 million in 2024Q3 from 9,461 million in 2024Q2 representing a change of 2.23%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 114 million in 2024Q3 from 125 million in 2024Q2 representing a change of -8.27%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	901827000	-16413000	5594.59
operating cash flow	1119206000	220053000	408.61
free cash flow	141801000	-1161522000	112.21
capital expenditure	-977405000	-1381575000	29.25
depreciation and amortization	553821000	399247000	38.72
deferred income tax	0	0	NaN
stock based compensation	55477000	49284000	12.57
accounts payables	368739000	423407000	-12.91
inventory	-599015000	-439029000	-36.44
acquisitions net	-1831573000	1020331000	-279.51
investments in property plant and equipment	-977405000	-1381575000	29.25
net cash used for investing activites	-945564000	-877405000	-7.77
debt repayment	-865545000	629322000	-237.54
common stock issued	1687430000	37918000	4350.21
common stock repurchased	-8988000	-9328000	3.64
dividends paid	0	0	NaN
net cash used provided by financing activities	735832000	635820000	15.73
cash at end of period	1477234000	575407000	156.73
accounts receivables	-1345427000	-133167000	-910.33
cash at beginning of period	575407000	591820000	-2.77

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 902 million in 2023 from -16 million in 2022 representing a change of 5594.59%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,119 million in 2023 from 220 million in 2022 representing a change of 408.61%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 142 million in 2023 from -1,162 million in 2022 representing a change of 112.21%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 369 million in 2023 from 423 million in 2022 representing a change of -12.91%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -1,345 million in 2023 from -133 million in 2022 representing a change of -910.33%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -977 million in 2023 from -1,382 million in 2022 representing a change of 29.25%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 55 million in 2023 from 49 million in 2022 representing a change of 12.57%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	-71632000	630866000	-111.35
free cash flow	-470490000	-20398000	-2206.55
capital expenditure	-398858000	-651264000	38.76
depreciation and amortization	156894000	153647000	2.11
deferred income tax	0	0	NaN
stock based compensation	14347000	23293000	-38.41
accounts receivables	33202000	-415548000	107.99
accounts payables	0	789566000	-100.00
inventory	-191868000	-209828000	8.56
acquisitions net	0	0	NaN
investments in property plant and equipment	-1841000	-651264000	99.72
net cash used for investing activites	150146000	-650586000	123.08
debt repayment	-484000	-1776000	72.75
common stock issued	120846000	2741000	4308.83
common stock repurchased	0	-27459000	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	109919000	-26494000	514.88
net change in cash	180290000	-44412000	505.95
cash at end of period	996692000	816402000	22.08
cash at beginning of period	816402000	860814000	-5.16

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 180 million in 2024Q3 from -44 million in 2024Q2 representing a change of 505.95%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation decreased to 14 million in 2024Q3 from 23 million in 2024Q2 representing a change of -38.41%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 790 million in 2024Q2 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to -72 million in 2024Q3 from 631 million in 2024Q2 representing a change of -111.35%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -470 million in 2024Q3 from -20 million in 2024Q2 representing a change of -2206.55%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -399 million in 2024Q3 from -651 million in 2024Q2 representing a change of 38.76%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 33 in 2024Q3 from -416 million in 2024Q2 representing a change of 107.99%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	92.06	44.74	105.76
net income per share	19.23	-4.93	489.83
operating cash flow per share	14.59	3.12	366.89
free cash flow per share	1.85	-16.49	111.21
cash per share	24.34	40.4	-39.75
book value per share	134.79	101.53	32.75
tangible book value per share	50.3	17.15	193.35
shareholders equity per share	134.79	101.53	32.75
interest debt per share	3.27	26.68	-87.75
market cap	13612289049.45	15027414600	-9.42
enterprise value	12280357049.45	16211339600	-24.25
pe ratio	9.23	-43.26	121.33
price to sales ratio	1.93	4.77	-59.59
pocfratio	12.16	68.29	-82.19
pfcf ratio	96.0	-12.94	841.98
pb ratio	1.32	2.1	-37.36
ptb ratio	1.32	2.1	-37.36
ev to sales	1.74	5.15	-66.20
enterprise value over ebitda	5.99	192.36	-96.89
ev to operating cash flow	10.97	73.67	-85.11
ev to free cash flow	86.6	-13.96	720.50
earnings yield	0.11	-0.02	568.81
free cash flow yield	0.01	-0.08	113.48
debt to equity	0.01	0.25	-94.29
debt to assets	0.01	0.14	-92.87
net debt to ebitda	-0.65	14.05	-104.62
current ratio	1.94	1.96	-1.15
interest coverage	14.19	-0.03	44277.46
income quality	0.76	-0.63	219.77
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.08	0.12	-35.83
research and ddevelopement to revenue	0.32	0.38	-15.98
intangibles to total assets	0.45	0.48	-5.84
capex to operating cash flow	0.87	6.28	-86.09
capex to revenue	0.14	0.44	-68.44
capex to depreciation	1.76	3.46	-49.00
stock based compensation to revenue	0.01	0.02	-49.78
graham number	241.5	106.16	127.49
roic	0.13	-0.0	35907.45
return on tangible assets	0.19	-0.05	447.90
graham net net	0.13	-21.93	100.57
working capital	2615182000	2197240000	19.02
tangible asset value	3858196000	1207350000	219.56
net current asset value	1389770000	-756679000	283.67
invested capital	11549603000	9891283000	16.77
average receivables	1150624500	452384500	154.35
average payables	780035000	434769500	79.41
average inventory	1281404000	699557500	83.17
days sales outstanding	91.9	60.6	51.64
days payables outstanding	137.35	152.58	-9.98
days of inventory on hand	236.62	231.43	2.24
receivables turnover	3.97	6.02	-34.05
payables turnover	2.66	2.39	11.09
inventory turnover	1.54	1.58	-2.19
roe	0.14	-0.05	393.65
capex per share	12.74	19.62	-35.06

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.23 on 2023-12-31 from -43.26 on 2022-12-31, representing a change of 121.33%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2023-12-31 from 0.25 on 2022-12-31, representing a change of -94.29%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.94 on 2023-12-31 from 1.96 on 2022-12-31, representing a change of -1.15%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
BAVA.CO
calendar year	2024	2024	NaN
revenue per share	17.41	18.04	-3.51
net income per share	0.9	3.3	-72.73
operating cash flow per share	-0.91	7.97	-111.47
free cash flow per share	-6.01	-0.26	-2230.26
cash per share	23.89	28.27	-15.49
book value per share	136.42	131.89	3.43
tangible book value per share	54.47	49.66	9.68
shareholders equity per share	136.42	131.89	3.43
interest debt per share	1.76	1.85	-4.66
market cap	18132108786	13582612490.05	33.50
enterprise value	17249717786	12890822490.05	33.81
pe ratio	64.31	13.0	394.51
price to sales ratio	13.3	9.51	39.77
pocfratio	-253.13	21.53	-1275.70
pfcf ratio	-38.54	-665.88	94.21
pb ratio	1.7	1.3	30.39
ptb ratio	1.7	1.3	30.39
ev to sales	12.65	9.03	40.11
enterprise value over ebitda	68.23	29.23	133.42
ev to operating cash flow	-240.81	20.43	-1278.50
ev to free cash flow	-36.66	-631.97	94.20
earnings yield	0.0	0.02	-79.78
free cash flow yield	-0.03	-0.0	-1627.82
debt to equity	0.01	0.01	-10.41
debt to assets	0.01	0.01	-6.13
net debt to ebitda	-3.49	-1.57	-122.49
current ratio	1.69	1.48	14.10
interest coverage	3.98	12.43	-67.94
income quality	-1.02	2.42	-142.06
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.09	0.09	-0.76
research and ddevelopement to revenue	0.19	0.15	32.03
intangibles to total assets	0.46	0.46	0.95
capex to operating cash flow	-5.57	1.03	-639.38
capex to revenue	0.29	0.46	-35.88
capex to depreciation	2.54	4.24	-40.02
stock based compensation to revenue	0.01	0.02	-35.51
graham number	52.56	98.96	-46.89
roic	0.01	0.02	-65.90
return on tangible assets	0.01	0.03	-72.15
graham net net	-3.83	-7.64	49.86
working capital	2110570000	1741133000	21.22
tangible asset value	4266326000	3929738000	8.57
net current asset value	1926160000	1552805000	24.04
invested capital	10841196000	10602285000	2.25
average receivables	0	331545000	-100.00
average payables	898783000	802530500	11.99
average inventory	2088649000	1887801000	10.64
days sales outstanding	0	0	NaN
days payables outstanding	77.26	143.07	-46.00
days of inventory on hand	250.86	253.47	-1.03
receivables turnover	0	0	NaN
payables turnover	1.16	0.63	85.19
inventory turnover	0.36	0.36	1.04
roe	0.01	0.03	-73.63
capex per share	5.09	8.23	-38.13

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-09-30 Q3 from 0.03 on 2024-06-30 Q2, representing a change of -73.63%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 64.31 on 2024-09-30 Q3 from 13.00 on 2024-06-30 Q2, representing a change of 394.51%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.69 on 2024-09-30 Q3 from 1.48 on 2024-06-30 Q2, representing a change of 14.10%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of -10.41%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None